10.1 Caries Risk Assessment Models (CAMBRA) & Personalised Prevention
Key Takeaways
- Caries Risk Assessment (CRA) transforms clinical dentistry from a reactive restorative model to an evidence-based, minimally invasive risk management model endorsed by the Australian Dental Association (ADA).
- The CAMBRA Caries Balance model weighs Disease Indicators (WREC: White spots, Restorations <3 yrs, Enamel lesions, Cavities into dentine) and Risk Factors (BAD: Bacteria, Absence of saliva, Dietary habits) against Protective Factors (SAFE: Saliva, Antibacterials, Fluoride, Effective diet).
- Salivary diagnostic testing provides quantitative markers for caries susceptibility, with normal stimulated salivary flow rate exceeding 1.0–1.5 mL/min, low flow at 0.7–1.0 mL/min, and severe hyposalivation below 0.5–0.7 mL/min.
- ICDAS staging (Codes 0–6) provides standardized criteria for visual-tactile lesion severity, guiding clinical decisions between non-operative remineralisation, micro-invasive sealing, and operative restoration.
- Extreme Caries Risk patients (High risk + severe hyposalivation, head and neck radiotherapy, or Sjögren's syndrome) require 3-monthly recalls, 5000 ppm NaF prescription toothpaste, 5% NaF varnish 3–4 times yearly, and non-acidic CPP-ACP pastes.
10.1 Caries Risk Assessment Models (CAMBRA) & Personalised Prevention
Contemporary dental practice in Australia has undergone a paradigm shift from traditional, reactive surgical intervention ("drill and fill") to evidence-based, patient-centred Caries Risk Assessment (CRA) and Minimally Invasive Dentistry (MID). Dental caries is recognized biologically as a complex biofilm-mediated, diet-modulated, multifactorial, non-communicable, dynamic disease that results in episodic demineralisation and remineralisation of dental hard tissues. Implementing systematic caries risk assessment frameworks—such as Caries Management by Risk Assessment (CAMBRA), the International Caries Detection and Assessment System (ICDAS), and the Australian Dental Association (ADA) Caries Risk Assessment tool—enables clinicians to identify disease etiology, predict future caries incidence, and tailor personalized preventive and therapeutic interventions.
1. The Caries Balance Concept: Disease Indicators, Risk Factors & Protective Factors
The foundation of CAMBRA rests on the Caries Balance Concept, which visualizes dental health as a continuous equilibrium between pathological factors promoting demineralisation and protective factors promoting remineralisation. A patient's net caries risk is determined by assessing three distinct clinical categories: Disease Indicators, Risk Factors, and Protective Factors.
A. Disease Indicators (WREC)
Disease indicators are clinical observations that directly signal ongoing or recent caries activity. The presence of any single disease indicator automatically places an adult or pediatric patient into a High Caries Risk category (or Extreme Risk if hyposalivation is present).
- W — White spot lesions: Visible non-cavitated smooth surface enamel lesions exhibiting chalky opacity.
- R — Restorations placed within the last 36 months: Any tooth restored due to active carious breakdown in the preceding 3 years.
- E — Enamel lesions radiographically visible: Approximal enamel radiolucencies (ICDAS/radiographic E1 or E2 lesions) that have not yet cavitated into dentine.
- C — Cavitated lesions into dentine: Active dentinal cavitations visible clinically or radiographically (D2 or D3 lesions).
B. Biological & Behavioral Risk Factors (BAD)
Risk factors are biological, environmental, or behavioral variables that directly contribute to acid production, bacterial dysbiosis, or impaired mineral recovery.
- B — Bacteria & Biofilm accumulation: Visible heavy plaque deposits (Plaque Index > 1) and elevated microbiological loads of Streptococcus mutans and Lactobacillus species.
- A — Absence of saliva / Hyposalivation: Reduced resting or stimulated salivary flow rates caused by polypharmacy (e.g., anticholinergics, antihistamines, antidepressants, antihypertensives), head and neck radiotherapy, Sjögren's syndrome, or systemic dehydration.
- D — Dietary habits: Frequent consumption (>3–4 times daily between meals) of fermentable carbohydrates, sugary beverages, acidic sports drinks, or nocturnal bottle-feeding with milk/juice in infants.
- Additional Clinical Risk Factors: Deep retentive occlusal pits and fissures, exposed root surfaces due to gingival recession, fixed orthodontic appliances, removable prostheses, and low socio-economic status or limited oral health literacy.
C. Protective Factors (SAFE)
Protective factors are biological mechanisms, therapeutic agents, or behavioral habits that offset pathological acid challenges and facilitate enamel/dentine remineralisation.
- S — Saliva & Sealants: Adequate stimulated salivary flow with robust bicarbonate buffering capacity; properly sealed pits and fissures.
- A — Antibacterials: Use of chlorhexidine rinses, xylitol chewing gum, or silver diamine fluoride (SDF) to suppress acidogenic oral microflora.
- F — Fluoride exposure: Community fluoridated tap water (0.6–1.1 mg/L), daily brushing with fluoridated toothpaste (1000–5000 ppm NaF), and professional topical fluoride varnish applications (5% NaF / 22,600 ppm F).
- E — Effective diet & Remineralising agents: Balanced non-cariogenic diet, consumption of protective foods (e.g., hard cheese containing casein and calcium), and application of Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP).
2. Clinical Assessment & ICDAS Lesion Staging
Accurate diagnosis of caries lesions requires visual-tactile inspection on clean, dry teeth under optimal dental light. The International Caries Detection and Assessment System (ICDAS) provides a standardized 2-digit coding matrix (the first digit representing tooth surface status/restoration, and the second digit representing carious lesion severity).
| ICDAS Code | Clinical Visual Appearance | Histological Depth | Recommended Clinical Management |
|---|---|---|---|
| Code 0 | Sound tooth structure; no change after 5 sec air-drying | No lesion | Routine primary prevention and recall |
| Code 1 | First visual change in enamel; visible only after 5 sec air-drying | Outer 1/2 of enamel (E1) | Non-operative: Topical fluoride, CPP-ACP, OHI |
| Code 2 | Distinct visual change in enamel; visible when wet | Inner 1/2 of enamel to outer 1/3 of dentine (E2/D1) | Non-operative remineralisation or micro-invasive sealant |
| Code 3 | Localised enamel breakdown without visible dentine underlying | Middle 1/3 of dentine (D2) | Micro-invasive sealant or ultraconservative restoration |
| Code 4 | Underlying dark shadow from dentine (grey/blue/brown) | Middle 1/3 to inner 1/3 of dentine | Operative minimally invasive restoration |
| Code 5 | Distinct cavity with visible dentine (< 50% surface) | Inner 1/3 of dentine (D3) | Operative restoration (selective caries removal) |
| Code 6 | Extensive distinct cavity with visible dentine (> 50% surface) | Deep dentine into pulp proximity | Operative restoration / Endodontic evaluation |
Tactile Examination Caution: Traditional sharp dental explorers must not be forcefully pressed into non-cavitated enamel lesions (ICDAS 1–2), as mechanical probing ruptures the intact surface zone of the lesion, creating an iatrogenic cavitation that prevents remineralisation.
3. Salivary Diagnostic Testing & Quantitative Parameters
Saliva is the primary innate defensive fluid against dental caries. Chairside salivary testing is indicated for patients presenting with rampant caries, unexplained lesion progression, or suspected xerostomia.
A. Salivary Flow Rate Measurement
- Resting (Unstimulated) Salivary Flow Rate: Measured by collecting passive drool over 5 minutes. Normal resting flow is 0.3–0.4 mL/min. A flow rate < 0.1 mL/min indicates severe resting hyposalivation.
- Stimulated Salivary Flow Rate: Measured while the patient chews a piece of paraffin wax for 5 minutes, spitting all saliva into a graduated tube.
- Normal Flow: > 1.0 to 1.5 mL/min.
- Low Flow (Moderate Risk): 0.7 to 1.0 mL/min.
- High Risk Hyposalivation: < 0.7 mL/min.
- Extreme Risk Hyposalivation: < 0.5 mL/min.
B. Buffering Capacity & Microbiologic Testing
- Bicarbonate Buffering System: Bicarbonate ions ($HCO_3^-$) in stimulated saliva neutralize bacterial metabolic acids ($H^+$) and elevate plaque pH above the critical threshold. Chairside test strips measure buffering capacity (categorised as Low/Red, Medium/Yellow, or High/Green).
- Microbiologic Assays: Chairside culturing (e.g., CRT Bacteria) or quantitative PCR quantifies colony-forming units per millilitre (CFU/mL):
- Streptococcus mutans $> 10^5$ CFU/mL indicates high acidogenic infection risk.
- Lactobacillus species $> 10^4$ CFU/mL indicates high fermentable carbohydrate exposure and active cavitated lesions.
4. Caries Risk Categorisation Matrix & Personalised Care Plans
Based on CAMBRA synthesis, patients are stratified into four distinct risk categories, each mandating a specific recall interval, diagnostic radiograph schedule, and clinical preventive protocol aligned with ADA guidelines.
| Caries Risk Category | Diagnostic Criteria & Profile | Recall Interval | Bitewing Radiograph Frequency | Personalised Preventive Care Protocol |
|---|---|---|---|---|
| Low Risk | No disease indicators (WREC = 0); no high-risk factors; adequate protective factors present. | 12 to 24 months | Every 24 to 36 months | - Standard toothpaste (1000–1450 ppm F)<br/>- Routine OHI and dietary advice<br/>- Optional fissure sealants for deep anatomy |
| Moderate Risk | No disease indicators; 1 to 2 risk factors present (e.g. frequent sugar intake, dry mouth complaints, low fluoride area). | 6 months | Every 18 to 24 months | - Standard toothpaste (1000–1450 ppm F)<br/>- Professional 5% NaF varnish (Duraphat) twice yearly<br/>- Xylitol gum (6–8g/day)<br/>- Pit and fissure sealants |
| High Risk | Presence of ANY disease indicator (active cavity, white spot, restoration <3 yrs) OR multiple high-risk factors. | 3 to 4 months | Every 6 to 12 months | - Prescription 5000 ppm NaF toothpaste (NeutraFluor 5000) daily for patients ≥10 years<br/>- Professional 5% NaF varnish every 3 months<br/>- Xylitol gum & chlorhexidine rinses (0.12% for 14 days/month)<br/>- CPP-ACP paste (Tooth Mousse) |
| Extreme Risk | High Caries Risk criteria PLUS severe hyposalivation (<0.5 mL/min stimulated flow, post-radiotherapy, Sjögren's). | 3 months | Every 6 months | - NeutraFluor 5000 toothpaste daily<br/>- 5% NaF varnish every 3 months<br/>- Non-acidic CPP-ACP paste (Tooth Mousse) multiple times daily<br/>- Salivary substitutes (carboxymethylcellulose/mucin sprays)<br/>- Custom fluoride gel trays (1.1% NaF) |
A 28-year-old male presents for a comprehensive dental examination. Clinical inspection reveals an active cavitated lesion into dentine on tooth 16 (ICDAS 5) and a smooth surface white spot lesion on tooth 21. His last restorative treatment was 18 months ago. He has normal salivary flow (1.4 mL/min). According to CAMBRA guidelines, what is his caries risk category and primary preventive home care recommendation?
During a chairside salivary diagnostic evaluation for a patient complaining of severe dry mouth, a clinician measures a stimulated salivary flow rate of 0.4 mL/min. Which interpretation of this result and underlying physiological mechanism is correct?
A clinician identifies a non-cavitated occlusal lesion on tooth 36 that exhibits a distinct visual opacity when wet (ICDAS Code 2). Radiographs show the lesion is confined to the outer enamel. Which clinical management strategy represents optimal minimally invasive dentistry?